HIGHLIGHTS
- who: Liselore M Janssen u200d et al. from the This is a prospective multicentre observational study in patients with breast cancer undergoing NACThe study has been approved by the Medical Ethics Review Committee of the University Medical Center Utrecht (19-u00ad, NL67308.041.19). Standard Protocol Items: Recommendations for Interventional Trials guidelines were followed [29]. In the LIMA study, the complementary expertise of investigators in the MRI and liquid biopsy field have been combined into a consortium. The study participants will be recruited in four different Dutch hospitals. Potential study participants are screened by their treating physicians . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.